Skip to main content

VIMIZIM

NDC 68135-100 · BioMarin Pharmaceutical Inc.

Generic nameelosulfase alfa
Dosage formINJECTION, SOLUTION, CONCENTRATE
RouteINTRAVENOUS
Active ingredient(s)ELOSULFASE ALFA
Strength5 mg/5mL
Pharmacologic classHydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC], alpha-Glucosidases [CS]
Marketing categoryBLA

Packages

68135-100-01 — 1 VIAL in 1 CARTON (68135-100-01) / 5 mL in 1 VIAL

Billed under HCPCS

J1322 — Injection, elosulfase alfa, 1 mg Medicare Part B payment limit (ASP + 6%): $319.52

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.